A handful of newly identified mutations may contribute to the development of kidney cancer, a Nature paper suggests.
Patients with clear cell renal cell carcinoma, the most common form of adult kidney cancer, frequently carry a mutation in the VHL gene. However, a large sequencing study of DNA of more than 3,500 genes from around 100 tumour samples highlights the presence of mutations in a variety of other genes.
Three of these genes are involved in modifying proteins called histones, which help package DNA into chromosomes in the nucleus and have a role in gene regulation. Recurrent mutations in the NF2 gene, which encodes a tumour suppressor protein, are also noted.
The study, by Andrew Futreal and colleagues, hints that a variety of different genetic subtypes may contribute to kidney cancer, and highlights the value of large-scale sequencing studies in uncovering genetic diversity.
Article DOI: 10.1038/nature08672
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.